Core Laboratories N.V. (CLB) Tops Q1 EPS by 6c, Guides FY13
Core Laboratories N.V. (NYSE: CLB) reported Q1 EPS of $1.22, $0.06 better than the analyst estimate ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
